<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effects of a selective inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase inhibitor <z:chebi fb="0" ids="40618">aminoguanidine</z:chebi> (AG) on neuronal cells survival in hippocampal CA1 region after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) were examined </plain></SENT>
<SENT sid="1" pm="."><plain>Transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was induced in rats by 60 or 90 min of MCAO, followed by 7 days of reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>AG treatment (150 mg/kg i.p.) significantly reduced total <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes: by 70% after 90 min MCAO and by 95% after 60 min MCAO, compared with saline-treated ischemic group </plain></SENT>
<SENT sid="3" pm="."><plain>The number of degenerating neurons in hippocampal CA1 region was also markedly lower in <z:chebi fb="0" ids="40618">aminoguanidine</z:chebi>-treated ischemic groups compared to ischemic groups without AG-treatment </plain></SENT>
<SENT sid="4" pm="."><plain>The number of iNOS-positive cells significantly increased in the hippocampal CA1 region of ischemic animals, whereas it was reduced in AG-treated rats </plain></SENT>
<SENT sid="5" pm="."><plain>Our findings demonstrate that <z:chebi fb="0" ids="40618">aminoguanidine</z:chebi> decreases ischemic brain damage and improves neurological recovery after transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced by MCAO </plain></SENT>
</text></document>